- Report
- March 2024
- 199 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- February 2024
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
- Report
- May 2024
- 182 Pages
Global
From €4767EUR$4,950USD£4,100GBP
- Report
- May 2024
- 173 Pages
Global
From €5248EUR$5,450USD£4,514GBP
- Report
- October 2023
- 145 Pages
Global
From €3033EUR$3,150USD£2,609GBP
- Report
- November 2023
- 140 Pages
Global
From €4285EUR$4,450USD£3,686GBP
- Report
- March 2024
- 185 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- March 2024
- 196 Pages
Global
From €3249EUR$3,374USD£2,794GBP
€3610EUR$3,749USD£3,105GBP
- Report
- February 2024
- 186 Pages
Global
From €4719EUR$4,900USD£4,058GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1204EUR$1,250USD£1,035GBP
- Report
- January 2024
- 96 Pages
Europe
From €2393EUR$2,485USD£2,058GBP
€3419EUR$3,550USD£2,940GBP
- Report
- January 2024
- 92 Pages
Middle East, Africa
From €2393EUR$2,485USD£2,058GBP
€3419EUR$3,550USD£2,940GBP
- Report
- December 2018
- 161 Pages
Global
From €1324EUR$1,375USD£1,139GBP
€2648EUR$2,750USD£2,278GBP
- Report
- August 2020
- 114 Pages
Global
From €4093EUR$4,250USD£3,520GBP
- Report
- January 2021
- 298 Pages
Global
From €6693EUR$6,950USD£5,756GBP
- Report
- January 2022
- 120 Pages
Global
From €2408EUR$2,500USD£2,071GBP
- Report
- April 2024
- 80 Pages
From €2499EUR$2,595USD£2,149GBP
- Report
- April 2024
- 80 Pages
From €2499EUR$2,595USD£2,149GBP
- Report
- April 2024
- 80 Pages
From €2499EUR$2,595USD£2,149GBP
- Report
- April 2024
- 80 Pages
From €2499EUR$2,595USD£2,149GBP
The Brain Tumor Drug market is a subset of the larger Brain Cancer Drug market. It is composed of drugs used to treat brain tumors, which are abnormal growths of cells in the brain. These drugs are used to reduce the size of the tumor, slow its growth, and reduce symptoms. They can be administered orally, intravenously, or intrathecally. Common drugs used to treat brain tumors include temozolomide, bevacizumab, and lomustine.
The Brain Tumor Drug market is highly competitive, with many companies vying for market share. Some of the major players in the market include Novartis, Pfizer, Merck, and Roche. Other companies in the market include Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more